Porcilis Lawsonia vet.
Active substance
ATC code
Species
Pigs.
Indications
For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection.
Onset of immunity: 4 weeks after vaccination.
Duration of immunity: 21 weeks after vaccination.
Dose to be administered and administration route
Intramuscular use.
Reconstitute the lyophilisate in the solvent or in Porcilis PCV M Hyo as follows:
Lyophilisate | Solvent or Porcilis PCV M Hyo |
50 doses | 100 ml |
100 doses | 200 ml |
For proper reconstitution and correct administration, use the following procedure:
1. Allow the solvent or Porcilis PCV M Hyo to reach room temperature and shake well before use.
2. Add 5-10 ml of the solvent or Porcilis PCV M Hyo to the lyophilisate and mix briefly.
3. Withdraw the reconstituted concentrate from the vial and transfer it back into the vial with the solvent or the Porcilis PCV M Hyo. Shake briefly to mix.
4. Use the vaccine suspension within 6 hours of reconstitution. Any vaccine remaining at the end of this time should be discarded.
Needle length and diameter should be adapted to the age of the animal. Avoid introduction of a contamination by multiple broaching.
Dosage:
A single dose of 2 ml of reconstituted vaccine in pigs starting at 3 weeks of age. Vaccinate pigs by the intramuscular route in the neck.
Visual appearance after reconstitution: homogenous white to nearly white emulsion after shaking.
Adverse reactions
Pigs:
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature 1 |
|
Common (1 to 10 animals / 100 animals treated): |
Injection site swelling 2 |
|
Uncommon (1 to 10 animals / 1 000 animals treated): |
Anorexia, Lethargy |
|
Very rare (<1 animal / 10 000 animals treated, including isolated reports): |
Anaphylactic-type reaction3 |
1 Mean of 0.6 °C, in individual pigs up to 1.3 °C. The animals return to normal temperature within 1 day after vaccination.
2 < 5 cm diameter, disappear within 23 days.
3 If such reactions occur, appropriate treatment is recommended.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
